Dow Jones

39,118.86

-0.12%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NYSE
Legacy Healthcare Properties (LRP)
Legacy Healthcare Properties (LRP) Noticias

LRP

Legacy Healthcare Properties (LRP)

Legacy Healthcare Properties

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:LRP

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/04/2011	14:30	Edgar (US Regulatory)	Withdrawal of Registration Statement (RW)	NYSE:LRP	Legacy Healthcare Properties
05/10/2010	05:21	Edgar (US Regulatory)	Securities Registration: Real Estate Company (S-11/A)	NYSE:LRP	Legacy Healthcare Properties
21/07/2008	14:24	PR Newswire (US)	/C O R R E C T I O N from Source -- Lorus Therapeutics Inc./	AMEX:LRP
21/07/2008	06:30	PR Newswire (US)	Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008	AMEX:LRP
16/07/2008	07:12	PR Newswire (US)	Lorus Therapeutics Receives $600 Thousand From Escrow Account	AMEX:LRP
09/07/2008	07:00	PR Newswire (US)	Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program	AMEX:LRP
02/07/2008	08:00	PR Newswire (US)	Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with	AMEX:LRP
23/06/2008	06:30	PR Newswire (US)	Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for t	AMEX:LRP
06/05/2008	15:22	PR Newswire (US)	AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing Standards	AMEX:LRP
05/05/2008	06:30	PR Newswire (US)	Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions	AMEX:LRP
22/04/2008	07:30	PR Newswire (US)	Lorus initiates development program exploring novel route of administration for LOR-2040	AMEX:LRP
16/04/2008	07:30	PR Newswire (US)	Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040	AMEX:LRP
08/04/2008	21:04	PR Newswire (US)	Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)	AMEX:LRP
22/01/2008	17:17	PR Newswire (US)	Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer	AMEX:LRP
06/11/2007	06:30	PR Newswire (US)	Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference	AMEX:LRP
19/09/2007	21:23	PR Newswire (US)	Lorus Therapeutics announces election of three new Directors and appoints a new Chairman	AMEX:LRP
29/08/2007	07:30	PR Newswire (US)	Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia	AMEX:LRP
23/07/2007	17:48	PR Newswire (US)	Lorus Therapeutics Announces the Appointment of a New Member of the Board of Directors	AMEX:LRP
10/07/2007	19:04	PR Newswire (US)	Lorus Therapeutics completes reorganization resulting in non dilutive financing	AMEX:LRP
05/07/2007	16:39	PR Newswire (US)	Lorus Therapeutics announces revised closing date for proposed plan of arrangement	AMEX:LRP
19/06/2007	08:30	PR Newswire (US)	Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndrome	AMEX:LRP
14/05/2007	08:30	PR Newswire (US)	Lorus announces presentation of corporate overview at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference	AMEX:LRP
01/05/2007	21:59	PR Newswire (US)	Lorus Therapeutics announces reorganization resulting in approximately $7,800,000 of non-dilutive financing	AMEX:LRP
19/04/2007	08:30	PR Newswire (US)	Lorus Therapeutics reports third quarter results for fiscal year 2007	AMEX:LRP
17/04/2007	08:30	PR Newswire (US)	Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Confe	AMEX:LRP
01/03/2007	07:00	PR Newswire (US)	Lorus Therapeutics Announces a Key Scientific Publication on Therapeutic siRNA in Cancer Therapy	AMEX:LRP
29/12/2006	06:00	PR Newswire (US)	Lorus Therapeutics reports second quarter results for fiscal year 2007	AMEX:LRP
06/11/2006	09:04	PR Newswire (US)	Lorus announces presentation of corporate overview at the Rodman and Renshaw 8th Annual Healthcare Conference	AMEX:LRP
01/11/2006	06:00	PR Newswire (US)	Lorus Therapeutics announces presentation on GTI-2040 uptake by tumor cells in acute myeloid leukemia	AMEX:LRP
25/10/2006	07:00	PR Newswire (US)	Lorus Therapeutics announces presentation of GTI-2040 pharmacokinetic and metabolic data in acute myeloid leukemia	AMEX:LRP